Allergan, Inc.

Urovant Sciences Gmbh

Jihao Zhou

Michael R Robinson

Anuradha V Gore

Mohammed I Dibas

Jaya Giyanani

Aileen Morgan

Haixia Liu

Sungwook Lee

Paul N Mudd, Jr

Cornelia Haag-molkenteller

Mohammed Dibas

Anuradha Gore

The present disclosure is directed to a method of treating overactive bladder symptoms in men with benign prostatic hyperplasia comprising orally administering to a subject in need thereof an amount of from about 60 mg to about 90 mg (e.g., about 75 mg) of vibegron per day.

Vibegron for the treatment of overactive bladder symptoms

Described herein are methods and compositions for the treatment of ocular conditions and for the improvement of vision parameters using pharmaceutically acceptable ophthalmic pilocarpine formulations. A nonlimiting example of an ocular condition that may be treated with the methods and compositions disclosed herein is presbyopia.

Presbyopia treatments

Growing community of inventors

Rancho Santa Margarita, CA, United States of America

Jihao Zhou